Peptide therapy TikTok claims: separating hype from human data

What did @kingclavicular actually say?

The claim is pretty direct: if you want to get as tan as possible while avoiding UV exposure, Melanotan II (MT2) is the answer. The creator frames this specifically for "looksmaxers," arguing that UV is "horrible for your longevity" and negatively affects collagen, so MT2 offers the result without the damage. That framing is more nuanced than most peptide content, but the conclusion still needs unpacking.

To be clear about what was said: "If you are a looksmaxer, your goal should be to get as tan as possible... with minimizing your exposure to UV." The logic is that MT2 triggers melanin production without requiring sun exposure as the stimulus. That part is broadly true. The problem is the leap to "absolutely no reason not to."

Does the science back this up?

Partially, yes. MT2 is a synthetic analogue of alpha-melanocyte stimulating hormone (alpha-MSH) and does stimulate melanogenesis through the MC1R receptor. Studies confirm it increases skin pigmentation. Dorr et al. (1996, Journal of Investigative Dermatology) demonstrated that MT2 produced significant tanning in human subjects at low UV doses compared to controls. So the mechanism is real.

However, the "no detriment" framing is where the science pushes back hard. MT2 is not approved by the FDA or EMA. It is associated with spontaneous erections, nausea, facial flushing, and fatigue in clinical studies. More concerning, there are documented case reports linking MT2 use to melanocytic lesion changes and at least one case of melanoma in a previously stable nevus (Larsabal et al., 2015, JAMA Dermatology). Whether MT2 promotes existing atypical moles is unresolved, but "absolutely no reason not to" ignores that literature entirely.

What did they get wrong (or right)?

They got the UV-collagen relationship right. Chronic UV exposure degrades collagen through matrix metalloproteinase activation and generates reactive oxygen species that accelerate photoaging. Fisher et al. (1997, Nature) showed UV-B induces MMP-1 and MMP-3 expression in human skin within hours. Wanting to minimize UV to protect skin integrity is sound reasoning.

What they got wrong is the implied safety profile. MT2 has never completed Phase III clinical trials. It is sold on grey markets, typically as a lyophilized powder for reconstitution, with no standardized dosing or purity guarantees. Calling it a no-downside solution for people who want cosmetic tanning glosses over real unknowns. The nevi concern alone, even if causality is not established, is not something to wave away for an aesthetic goal. The creator also does not mention the cardiovascular effects at melanocortin receptors, which include transient blood pressure changes noted in early trials by Van der Ploeg et al. (2002, Nature).

What should you actually know?

MT2 works as a tanning agent mechanistically. That is not in dispute. But "minimizing UV" with MT2 does not mean zero UV in most real-world use cases, because many users still expose themselves to some sun to activate or maintain the effect. The peptide accelerates melanin synthesis, but whether that melanin is photoprotective in the same way as UV-stimulated melanin is not well established in long-term human data.

If you have a personal or family history of melanoma, dysplastic nevi, or are on immunosuppressants, using an unregulated melanocortin agonist without dermatological monitoring is a meaningful risk. Any cosmetic use of MT2 should involve a baseline skin check and monitoring of existing moles. The "looksmaxing" framing also obscures a clinical reality: the people most motivated to use this are often young men who may not think about melanoma risk as immediately relevant to them, but who may carry genetic predispositions they are unaware of.

MT2 is not legally available as a licensed pharmaceutical in the US or EU. Access through compounding pharmacies or grey-market sources means variable product quality. That is a real safety variable the video does not address.